Sanofi Secures World First Approval For Dupixent In COPD With EU Nod
The French drugmaker can now boast seven approvals for its huge-earning IL-4/IL-13 inhibitor.
The French drugmaker can now boast seven approvals for its huge-earning IL-4/IL-13 inhibitor.